MSI-H Colorectal Cancer
14 clinical trials · Condition
◉ Watch MSI-H Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy (NCT06414304) | OncoAtlas LLC | 2022-06-01 |
| Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NCT04730544) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2021-05-21 |
| A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies (NCT04440943) | Celldex Therapeutics | 2020-08-04 |
| PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer (NCT04301557) | Sun Yat-sen University | 2020-07-31 |
| A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies (NCT04244552) | Atreca, Inc. | 2020-02-11 |
| Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NCT03983993) | Emory University | 2019-10-15 |
Track MSI-H Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.